Today in Medicine: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Medicine.

Press releases published on May 28, 2026

Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
Repairon annonce la publication dans le NEJM des résultats de l’essai clinique BIOVAT-HF, une thérapie innovante pour l’insuffisance cardiaque avancée
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Pacira’s Director Nominees
CDT Equity Inc. Announces Receipt of Nasdaq Deficiency Letter
LB Pharmaceuticals to Participate in Upcoming June Investor Events
Assembly Biosciences Announces Upcoming Investor Conference Presentations
Equillium to Participate in the 2026 Jefferies Global Healthcare Conference
rYojbaba Rings the Nasdaq Stock Market Opening Bell,  Celebrating Its Mission to “Fight Poverty” on the Global Stage
CG Oncology to Present at Upcoming Investor Conferences in June
Kailera Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
Apogee Therapeutics to Participate in Upcoming June Conferences
Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference
Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
HealthEquity Reports First Quarter Ended April 30, 2026 Financial Results; Raises Guidance
Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy
Advanced Chiropractic Relief Offers Ring Dinger® Spinal Decompression in Houston
Sharp Therapeutics Presents New Preclinical Data Supporting Novel Small-Molecule Therapeutic Approach for Niemann-Pick Disease Type C
Outlook Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Regeneron’s Ebola Antibody Recommended by World Health Organization for Investigational Use in Response to Current Bundibugyo Ebolavirus Outbreak
Parexel to Present Real-World Oncology Research and Launch New Patient-Focused Campaign at ASCO 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Today in Medicine

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.